ANTIMICROBIAL ACTIVITY OF A NOVEL POLYMYXIN ANALOG (CB-182,804) TESTED AGAINST CLINICAL STRAINS OF GRAM-NEGATIVE BACILLI, INCLUDING COLISTIN-RESISTANT ORGANISMS